Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers.

Purpose: The purpose of this study was to report toxicity and long-term survival outcomes of 2 prospective trials evaluating mitomycin C (MMC) with 5-fluorouracil-based adjuvant chemoradiation in resected periampullary adenocarcinoma.

Methods And Materials: From 1996 to 2002, 119 patients received an adjuvant 4-drug chemotherapy regimen of 5-fluorouracil, leucovorin, MMC, and dipyridamole with chemoradiation on 2 consecutive trials (trials A and B). Trial A patients received upfront chemoradiation (50 Gy split-course, 2.

The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study.

Background: Obesity significantly impacts the cost of cancer treatment, yet the impact of morbid obesity on inpatient hospital charges related to endometrial cancer treatment is not well-defined.

Objectives: The purpose of this study was to determine the charges that are associated with inpatient surgery, hospitalization, and postoperative care of morbidly obese patients with endometrial cancer.

Study Design: Data were obtained from the National Inpatient Sample from 2010.

Complete resolution of postoperative hemiparesis following carotid endarterectomy with therapeutic hypothermia: a case study and literature review.

Therapeutic hypothermia is indicated in a number of traumatic brain injuries as well as for cardiovascular shock (Warner DS, James ML, Laskowitz, et al. Translational research in acute central nervous system injury: lessons learned and the future. JAMA Neurol 2014;71:1311-1318), but it has been limited in its application to acute ischemic stroke.

Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.

Objective: The fallopian tube has been implicated as the primary origin of pelvic serous cancers. We proposed to determine the survival outcomes of serous tubal, ovarian, peritoneal, and uterine cancer patients.

Study Design: Data were obtained from the National Cancer Institute between 2004 and 2009.